semaglutide the same as glp 1 vs. GLP-1: Understanding Key Differences Microdosed GLP-1 (Semaglutide)

GLP-1 receptor agonists (GLP-1RAs), initially approved for diabetes and obesity, are now under investigation for neuroprotective effects in a range of neurological disorders

Glucagon increases blood glucose levels, particularly during fasting, and facilitates the mobilization of energy reserves.Synthetic agonists like semaglutide and tirzepatide are stable peptides that specifically activate the receptors of these hormones, amplifying their beneficial effects on glycemic control and weight management

A once marginal obesity treatment category is rapidly becoming a $200 billion global market opportunity.

Lately, we have been getting a lot of patients taking medications like Ozempic, Wegovy, and Mounjaro

IQVIA notes six big shifts in medicines use in 2023: Growing use of immunology treatments up 60% from 2019 with treatment of Crohns disease and psoriasis up 26% and 15%, respectively Rising use of novel obesity drugs which is the GLP-1 story Ill relate to the next graphic, below